APLT Applied Therapeutics Inc

Price (delayed)

$14.11

Market cap

$368.01M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.66

Enterprise value

$285.58M

Sector: Healthcare
Industry: Biotechnology

Highlights

APLT's debt is down by 16% year-on-year and by 6% since the previous quarter
The equity has surged by 65% since the previous quarter but it has declined by 13% year-on-year
The quick ratio has surged by 64% since the previous quarter but it has dropped by 59% year-on-year
The company's net income has shrunk by 115% YoY and by 13% QoQ
The company's EPS fell by 37% YoY and by 9% QoQ

Key stats

What are the main financial stats of APLT
Market
Shares outstanding
26.08M
Market cap
$368.01M
Enterprise value
$285.58M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.71
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$105.26M
EBITDA
-$104.87M
Free cash flow
-$81.57M
Per share
EPS
-$4.66
Free cash flow per share
-$3.38
Book value per share
$5.2
Revenue per share
$0
TBVPS
$6.47
Balance sheet
Total assets
$156.22M
Total liabilities
$21M
Debt
$1.64M
Equity
$135.22M
Working capital
$134.63M
Liquidity
Debt to equity
0.01
Current ratio
7.81
Quick ratio
7.49
Net debt/EBITDA
0.79
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-78.9%
Return on equity
-94%
Return on invested capital
-245.2%
Return on capital employed
-77.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APLT stock price

How has the Applied Therapeutics stock price performed over time
Intraday
-0.49%
1 week
-19.05%
1 month
-15.05%
1 year
-67.18%
YTD
-35.89%
QTD
-24.79%

Financial performance

How have Applied Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$106.19M
Net income
-$105.77M
Gross margin
N/A
Net margin
N/A
Applied Therapeutics's operating income has plunged by 115% YoY and by 12% from the previous quarter
The company's net income has shrunk by 115% YoY and by 13% QoQ

Growth

What is Applied Therapeutics's growth rate over time

Valuation

What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
2.71
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 37% YoY and by 9% QoQ
The equity has surged by 65% since the previous quarter but it has declined by 13% year-on-year
APLT's price to book (P/B) is 46% less than its last 4 quarters average of 5.1

Efficiency

How efficient is Applied Therapeutics business performance
APLT's return on invested capital is down by 26% year-on-year and by 21% since the previous quarter
The return on equity has declined by 24% year-on-year and by 18% since the previous quarter
The return on assets has declined by 20% year-on-year and by 15% since the previous quarter

Dividends

What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APLT.

Financial health

How did Applied Therapeutics financials performed over time
The total liabilities has soared by 109% YoY but it has decreased by 7% from the previous quarter
The quick ratio has surged by 64% since the previous quarter but it has dropped by 59% year-on-year
APLT's debt is 99% smaller than its equity
The equity has surged by 65% since the previous quarter but it has declined by 13% year-on-year
The company's debt to equity has shrunk by 50% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.